Agile Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 623.7%.

Top 25 shareholders own 3.74% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.58%	Armistice Capital LLC	108,000	US$43.7k	10.2%	no data
0.86%	Renaissance Technologies LLC	59,200	US$24.0k	0%	no data
0.3%	The Vanguard Group, Inc.	20,477	US$8.3k	1,230%	no data
0.28%	Citadel Advisors LLC	19,247	US$7.8k	50.1%	no data
0.2%	Geode Capital Management, LLC	13,748	US$5.6k	-0.3%	no data
0.16%	State Street Global Advisors, Inc.	10,843	US$4.4k	0%	no data
0.11%	JPMorgan Chase & Co, Brokerage and Securities Investments	7,712	US$3.1k	122%	no data
0.084%	BlackRock, Inc.	5,745	US$2.3k	-4.88%	no data
0.048%	Tower Research Capital LLC	3,276	US$1.3k	49.5%	no data
0.029%	Advisory Services Network, LLC	2,020	US$817.6	0%	no data
0.026%	Investor AB (publ)	1,754	US$709.9	0%	no data
0.02%	UBS Asset Management AG	1,387	US$561.5	0%	no data
0.019%	Alfred Altomari	1,286	US$520.7	-0.08%	no data
0.012%	Royal Bank of Canada, Banking & Securities Investments	798	US$323.1	214%	no data
0.0026%	Citigroup Inc.,Banking and Securities Investments	181	US$73.3	0%	no data
0.0012%	Scott Coiante	80	US$32.5	0%	no data
0.00066%	Morgan Stanley, Investment Banking and Brokerage Investments	45	US$18.3	0%	no data
0.00063%	Bg Fund Management Luxembourg S.A.	43	US$17.5	0%	no data
0.00058%	John Hubbard	40	US$16.1	42.9%	no data
0.00058%	Seth H. Fischer	40	US$16.1	42.9%	no data
0.00057%	Josephine Torrente	39	US$15.8	200%	no data
0.00055%	Sandra Carson	38	US$15.3	46.2%	no data
0.00055%	Sharon Barbari	38	US$15.3	81%	no data
0.00045%	Ajit S. Shetty	31	US$12.5	0%	no data
0.00044%	Geoffrey Gilmore	30	US$12.2	-25%	no data